3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
68
Leukemia
56
Myelodysplastic Syndromes
53
Lymphoma
47
Precursor Cell Lymphoblastic Leukemia-Lymphoma
46
Lymphoma, Non-Hodgkin
43
Multiple Myeloma
40
Hodgkin Disease
39
Leukemia, Lymphocytic, Chronic, B-Cell
35
Congenital Abnormalities
30
Lymphoma, Follicular
28
Lymphoma, Large B-Cell, Diffuse
27
Lymphoma, Mantle-Cell
26
Neoplasms, Plasma Cell
25
Lymphoma, B-Cell, Marginal Zone
24
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
23
Burkitt Lymphoma
23
Myeloproliferative Disorders
22
Lymphoma, Large-Cell, Immunoblastic
22
Leukemia, Myelomonocytic, Chronic
22
Blast Crisis
22
Leukemia, Myeloid, Chronic-Phase
21
Leukemia, Myeloid, Accelerated Phase
21
Primary Myelofibrosis
19
Lymphoma, T-Cell, Cutaneous
15
Hematologic Neoplasms
15
Graft vs Host Disease
15
Dendritic Cell Sarcoma, Interdigitating
14
Anemia, Refractory, with Excess of Blasts
14
Waldenstrom Macroglobulinemia
13
Interventions
temsirolimus
1
sargramostim
1
ruxolitinib
1
rucaparib
1
pazopanib
1
olaparib
1
eltrombopag
1
cc-486
1
Surveys and Questionnaires
1
Nivolumab
1
Monatide (IMS 3015)
1
Granulocyte-Macrophage Colony-Stimulating Factor
1
Doxorubicin
1
Docetaxel
1
Diphenhydramine
1
Cytarabine
1
Cyclophosphamide
1
Azacitidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Pathologic Complete Response
×
Busulfan
×
Clear all
No trials found.